| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
58,332 |
53,154 |
$2.21M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,351 |
10,143 |
$713K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,583 |
9,400 |
$703K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
29,139 |
22,072 |
$681K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,705 |
5,606 |
$410K |
| 90461 |
|
9,767 |
9,391 |
$291K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,934 |
1,903 |
$160K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,226 |
8,834 |
$131K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,492 |
3,643 |
$109K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,044 |
3,927 |
$104K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,130 |
2,047 |
$96K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,179 |
1,114 |
$77K |
| 99051 |
|
7,336 |
7,086 |
$37K |
| 95115 |
|
2,621 |
1,668 |
$27K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
787 |
766 |
$16K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
356 |
345 |
$11K |
| 0071A |
|
263 |
227 |
$9K |
| 99188 |
|
521 |
516 |
$8K |
| 90670 |
|
7,015 |
6,868 |
$8K |
| 0072A |
|
222 |
204 |
$8K |
| 90633 |
|
5,701 |
5,605 |
$7K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
121 |
116 |
$6K |
| 90680 |
|
4,296 |
4,195 |
$4K |
| 90698 |
|
4,842 |
4,734 |
$4K |
| 80061 |
Lipid panel |
151 |
151 |
$2K |
| 95117 |
|
160 |
106 |
$2K |
| 90687 |
|
1,857 |
1,823 |
$1K |
| 90744 |
|
2,096 |
2,048 |
$1K |
| 90473 |
|
121 |
120 |
$1K |
| 99462 |
|
55 |
54 |
$1K |
| 92583 |
|
60 |
57 |
$1K |
| 96127 |
|
350 |
335 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
51 |
50 |
$1K |
| 90688 |
|
3,065 |
3,010 |
$1K |
| 99460 |
|
16 |
16 |
$793.44 |
| 82947 |
|
152 |
152 |
$709.87 |
| 0001A |
|
21 |
16 |
$640.00 |
| 0002A |
|
15 |
15 |
$600.00 |
| 92551 |
|
53 |
51 |
$539.15 |
| 90651 |
|
248 |
247 |
$524.04 |
| 85018 |
|
203 |
200 |
$456.07 |
| 96161 |
|
276 |
251 |
$410.28 |
| 83655 |
|
25 |
25 |
$366.35 |
| 90716 |
|
90 |
90 |
$299.84 |
| 87807 |
|
30 |
27 |
$284.92 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
27 |
27 |
$280.84 |
| 90648 |
|
65 |
65 |
$257.60 |
| 90734 |
|
395 |
389 |
$217.32 |
| 90707 |
|
101 |
101 |
$205.70 |
| 90700 |
|
116 |
116 |
$175.67 |
| 90710 |
|
89 |
88 |
$175.60 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$143.13 |
| 36416 |
|
245 |
244 |
$58.15 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
14 |
13 |
$43.91 |
| 90715 |
|
54 |
53 |
$36.80 |
| 81002 |
|
12 |
12 |
$6.02 |
| 90696 |
|
49 |
49 |
$5.00 |
| 91307 |
|
304 |
275 |
$0.00 |
| 3008F |
|
78 |
78 |
$0.00 |
| 90619 |
|
12 |
12 |
$0.00 |
| 90672 |
|
187 |
186 |
$0.00 |
| 91300 |
|
49 |
48 |
$0.00 |